News
The company partnered with InStride to design customized skills-based opportunities for workers, offering over 800 pathways ...
Medtronic (NYSE:MDT) shares snapped six straight sessions of gains, as the stock was down 1% at $91.99 on Monday.
The company showcases solid financial health with steady revenue, strong free cash flow, and reliable earnings.
Holton was a graduate student in her early 20s when she lost her own mother to metastatic breast cancer. The experience left ...
2d
Medical Device Network on MSNMedtronic’s INFUSE Bone Graft trial meets predefined early success criteriaMedtronic has announced that an independent Data Monitoring Committee (DMC) reviewed the initial interim analysis and ...
The stock's fall snapped a six-day winning streak.
1d
Zacks.com on MSNMedtronic (MDT) Stock Sinks As Market Gains: What You Should KnowIn the latest trading session, Medtronic (MDT) closed at $91.97, marking a -1.04% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.02% for the day. At the ...
6d
Barchart on MSNHere's What to Expect From Medtronic's Next Earnings ReportMedtronic is all set to release its fiscal first-quarter earnings later next month, and analysts project earnings in line ...
On July 18, 2025, the US Court of Appeals for the Federal Circuit reversed a lower court ruling in Colibri Heart Valve LLC v. Medtronic ...
A U.S. appeals court on Friday overturned a jury's verdict that medical device maker Medtronic owes competitor Colibri $106.5 ...
COLIBRI HEART VALVE LLC v. MEDTRONIC COREVALVE, LLC - Before Taranto, Hughes, and Stoll. Appeal from the United States District Court for the ...
Medtronic, a leading Healthcare Technology company, announces a partnership with world number 3 tennis player Alexander ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results